Influenza A induced cellular signal transduction pathways

Journal of Thoracic Disease

Volumn 5, Issue SUPPL.2, 2013, Pages

  Michael, Paul ^a   Brabant, Danielle ^a   Bleiblo, Farag ^a,b   Ramana, Chilakamarti V ^c   Rutherford, Michael ^d,e   Khurana, Sandhya ^a,e   Tai, T C ^a,e   Kumar, Anand ^f   Kumar, Aseem ^a,e  

^a LAURENTIAN UNIVERSITY   (Canada)

^b UNIVERSITY OF BENGHAZI   (Libyan Arab Jamahiriya)

^c YALE UNIVERSITY   (United States)

^d Department of Pathology Health Sciences North ^*  (Canada)

^e NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cellular signal transduction; Influenza A; Viral pneumonia

Indexed keywords

SINGLE STRANDED RNA; VIRUS RNA;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; BACTERIAL INFECTION; DISEASE COURSE; HUMAN; IMMUNE SYSTEM; INFLUENZA A; INFLUENZA VIRUS A; INNATE IMMUNITY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; RESPIRATORY FAILURE; REVIEW; SIGNAL TRANSDUCTION; VIRAL CLEARANCE; VIRUS DETECTION; VIRUS MORPHOLOGY; VIRUS MUTATION; VIRUS PNEUMONIA; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS STRAIN;

EID: 84904720643     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2013.07.42     Document Type: Review

References (87)

1. Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010;59:1057-1062.
2. Dawood FS, Iuliano AD, Reed C, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012;12:687-695.
3. Howard WA, Peiris M, Hayden FG. Report of the 'mechanisms of lung injury and immunomodulator interventions in influenza' workshop, 21 March 2010, Ventura, California, USA. Influenza Other Respi Viruses 2011;5:453-4, e458-75.
4. Belser JA, Maines TR, Tumpey TM, et al. Influenza A virus transmission: contributing factors and clinical implications. Expert Rev Mol Med 2010;12:e39.
5. Yang W, Elankumaran S, Marr LC. Concentrations and size distributions of airborne influenza A viruses measured indoors at a health centre, a day-care centre and on aeroplanes. J R Soc Interface 2011;8:1176-1184.
6. Lakdawala SS, Subbarao K. The ongoing battle against influenza: The challenge of flu transmission. Nat Med 2012;18:1468-1470.
7. Yang W, Marr LC. Dynamics of airborne influenza A viruses indoors and dependence on humidity. PLoS One 2011;6:e21481.
8. Yang W, Elankumaran S, Marr LC. Relationship between humidity and influenza A viability in droplets and implications for influenza's seasonality. PLoS One 2012;7:e46789.
9. Azziz Baumgartner E, Dao CN, Nasreen S, et al. Seasonality, timing, and climate drivers of influenza activity worldwide. J Infect Dis 2012;206:838-846.
10. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005;5:718-725.
11. Van Reeth K. Cytokines in the pathogenesis of influenza. Vet Microbiol 2000;74:109-116.
12. Coloma R, Valpuesta JM, Arranz R, et al. The structure of a biologically active influenza virus ribonucleoprotein complex. PLoS Pathog 2009;5:e1000491.
13. Fournier E, Moules V, Essere B, et al. A supramolecular assembly formed by influenza A virus genomic RNA segments. Nucleic Acids Res 2012;40:2197-2209.
14. Klumpp K, Ruigrok RW, Baudin F. Roles of the influenza virus polymerase and nucleoprotein in forming a functional RNP structure. EMBO J 1997;16:1248-1257.
15. Zheng W, Tao YJ. Structure and assembly of the influenza A virus ribonucleoprotein complex. FEBS Lett 2013;587:1206-1214.
16. Gerl MJ, Sampaio JL, Urban S, et al. Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane. J Cell Biol 2012;196:213-221.
17. Schaap IA, Eghiaian F, des Georges A, et al. Effect of envelope proteins on the mechanical properties of influenza virus. J Biol Chem 2012;287:41078-41088.
18. Bertram S, Glowacka I, Steffen I, et al. Novel insights into proteolytic cleavage of influenza virus hemagglutinin. Rev Med Virol 2010;20:298-310.
19. Hamilton BS, Gludish DW, Whittaker GR. Cleavage activation of the human-adapted influenza virus subtypes by matriptase reveals both subtype and strain specificities. J Virol 2012;86:10579-10586.
20. Upham JP, Pickett D, Irimura T, et al. Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry. J Virol 2010;84:3730-3737.
21. Leung HS, Li OT, Chan RW, et al. Entry of influenza A Virus with a a2,6-linked sialic acid binding preference requires host fibronectin. J Virol 2012;86:10704-10713.
22. Fontana J, Cardone G, Heymann JB, et al. Structural changes in Influenza virus at low pH characterized by cryo-electron tomography. J Virol 2012;86:2919-2929.
23. Schnell JR, Chou JJ. Structure and mechanism of the M2 proton channel of influenza A virus. Nature 2008;451:591-5.
24. Lee KK. Architecture of a nascent viral fusion pore. EMBO J 2010;29:1299-1311.
25. Martin K, Helenius A. Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol 1991;65:232-244.
26. O'Neill RE, Jaskunas R, Blobel G, et al. Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J Biol Chem 1995;270:22701-22704.
27. Umbach JL, Yen HL, Poon LL, et al. Influenza A virus expresses high levels of an unusual class of small viral leader RNAs in infected cells. MBio 2010;1. pii: e00204-e00210.
28. Perez JT, Zlatev I, Aggarwal S, et al. A small-RNA enhancer of viral polymerase activity. J Virol 2012;86:13475-13485.
29. Widjaja I, de Vries E, Rottier PJ, et al. Competition between influenza A virus genome segments. PLoS One 2012;7:e47529.
30. Yu M, Liu X, Cao S, et al. Identification and characterization of three novel nuclear export signals in the influenza A virus nucleoprotein. J Virol 2012;86:4970-80.
31. Cao S, Liu X, Yu M, et al. A nuclear export signal in the matrix protein of Influenza A virus is required for efficient virus replication. J Virol 2012;86:4883-91.
32. Kawaguchi A, Matsumoto K, Nagata K. YB-1 functions as a porter to lead influenza virus ribonucleoprotein complexes to microtubules. J Virol 2012;86:11086-95.
33. Wang S, Li H, Chen Y, et al. Transport of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 and Cdc42 proteins. J Biol Chem 2012;287:9804-9816.
34. Kerviel A, Thomas A, Chaloin L, et al. Virus assembly and plasma membrane domains: which came first? Virus Res 2013;171:332-340.
35. Rossman JS, Jing X, Leser GP, et al. Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 2010;142:902-913.
36. Ruuskanen O, Lahti E, Jennings LC, et al. Viral pneumonia. Lancet 2011;377:1264-75.
37. Herold S, von Wulffen W, Steinmueller M, et al. Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J Immunol 2006;177:1817-1824.
38. Geiler J, Michaelis M, Sithisarn P, et al. Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses. Med Microbiol Immunol 2011;200:53-60.
39. Carnesecchi S, Pache JC, Barazzone-Argiroffo C. NOX enzymes: potential target for the treatment of acute lung injury. Cell Mol Life Sci 2012;69:2373-85.
40. Wolk KE, Lazarowski ER, Traylor ZP, et al. Influenza A virus inhibits alveolar fluid clearance in BALB/c mice. Am J Respir Crit Care Med 2008;178:969-76.
41. MacCallum NS, Evans TW. Epidemiology of acute lung injury. Curr Opin Crit Care 2005;11:43-49.
42. Hawgood S, Brown C, Edmondson J, et al. Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J Virol 2004;78:8565-8572.
43. Mittal N, Sanyal SN. Effect of exogenous surfactant on phosphatidylinositol 3-kinase-Akt pathway and peroxisome proliferator activated receptor-γ during endotoxin induced acute respiratory distress syndrome. Mol Cell Biochem 2012;361:135-141.
44. Armstrong SM, Wang C, Wang Y, et al. Influenza Primes Human Lung Microvascular Endothelium To Leak Upon Exposure To Staphylococcus Aureus. In: Anonymous. eds. American Thoracic Society International Conference Abstracts 2013;187:Meeting Abstracts.
45. Metersky ML, Masterton RG, Lode H, et al. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis 2012;16:e321-31.
46. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008;198:962-970.
47. Liderot K, Ahl M, Ozenci V. Secondary Bacterial Infections in Patients with Seasonal Influenza A and Pandemic H1N1. Biomed Res Int 2013;2013:376219.
48. Giamarellos-Bourboulis EJ, Raftogiannis M, Antonopoulou A, et al. Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS One 2009;4:e8393.
49. van der Sluijs KF, van Elden LJ, Nijhuis M, et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 2004;172:7603-7609.
50. Haynes L, Szaba FM, Eaton SM, et al. Immunity to the conserved influenza nucleoprotein reduces susceptibility to secondary bacterial infections. J Immunol 2012;189:4921-4929.
51. Julkunen I, Sareneva T, Pirhonen J, et al. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 2001;12:171-180.
52. Kash JC, Tumpey TM, Proll SC, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006;443:578-581.
53. Kobasa D, Jones SM, Shinya K, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007;445:319-323.
54. Ramana CV, Gil MP, Schreiber RD, et al. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol 2002;23:96-101.
55. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005;5:375-386.
56. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002;109 Suppl:S81-s96.
57. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001;11:327-377.
58. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001;104:487-501.
59. Bouwmeester T, Bauch A, Ruffner H, et al. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 2004;6:97-105.
60. Pleschka S, Wolff T, Ehrhardt C, et al. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat Cell Biol 2001;3:301-305.
61. Olschläger V, Pleschka S, Fischer T, et al. Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice. Oncogene 2004;23:6639-6646.
62. Conze D, Lumsden J, Enslen H, et al. Activation of p38 MAP kinase in T cells facilitates the immune response to the influenza virus. Mol Immunol 2000;37:503-513.
63. Ludwig S, Ehrhardt C, Neumeier ER, et al. Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J Biol Chem 2001;276:10990-10998.
64. Flory E, Kunz M, Scheller C, et al. Influenza virus-induced NF-kappaBdependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase. J Biol Chem 2000;275:8307-8314.
65. Pinto R, Herold S, Cakarova L, et al. Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo. Antiviral Res 2011;92:45-56.
66. Bleiblo F, Michael P, Brabant D, et al. The role of immunostimulatory nucleic acids in septic shock. Int J Clin Exp Med 2012;5:1-23.
67. Jensen S, Thomsen AR. Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion. J Virol 2012;86:2900-2910.
68. Mahalingam S, Karupiah G. Chemokines and chemokine receptors in infectious diseases. Immunol Cell Biol 1999;77:469-475.
69. Zhou J, Law HK, Cheung CY, et al. Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J Infect Dis 2006;194:61-70.
70. Loo YM, Fornek J, Crochet N, et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008;82:335-345.
71. Pichlmair A, Schulz O, Tan CP, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006;314:997-1001.
72. Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006;6:644-658.
73. Pauli EK, Schmolke M, Wolff T, et al. Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog 2008;4:e1000196.
74. Le Goffic R, Balloy V, Lagranderie M, et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2006;2:e53.
75. Le Goffic R, Pothlichet J, Vitour D, et al. Cutting Edge: Influenza A virus activates TLR3 dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 2007;178:3368-3372.
76. Zheng X, Bevilacqua PC. Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails. RNA 2004;10:1934-1945.
77. Wu S, Kaufman RJ. A model for the double-stranded RNA (dsRNA)-dependent dimerization and activation of the dsRNA-activated protein kinase PKR. J Biol Chem 1997;272:1291-1296.
78. Samuel CE. The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. J Biol Chem 1993;268:7603-7606.
79. Khaperskyy DA, Hatchette TF, McCormick C. Influenza A virus inhibits cytoplasmic stress granule formation. FASEB J 2012;26:1629-1639.
80. Onomoto K, Jogi M, Yoo JS, et al. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS One 2012;7:e43031.
81. Österlund P, Strengell M, Sarin LP, et al. Incoming influenza A virus evades early host recognition, while influenza B virus induces interferon expression directly upon entry. J Virol 2012;86:11183-1193.
82. Silverman RH. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 2007;81:12720-1279.
83. Anderson BR, Muramatsu H, Jha BK, et al. Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L. Nucleic Acids Res 2011;39:9329-9338.
84. Zhou A, Hassel BA, Silverman RH. Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 1993;72:753-765.
85. Wreschner DH, McCauley JW, Skehel JJ, et al. Interferon action--sequence specificity of the ppp(A2'p)nA-dependent ribonuclease. Nature 1981;289:414-417.
86. Malathi K, Dong B, Gale M Jr, et al. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007;448:816-819.
87. Hale BG, Randall RE, Ortín J, et al. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 2008;89:2359-2376.